Sequana Medical NV
SEQUA.BR
| Exchange: | BR |
| Currency | Euro |
| ISIN: | BE0974340722 |
| LEI: | 8755009AN12Y4PEOII07 |
| Primary Ticker: | SEQUA.BR |
| Fiscal Year End: | December |
| Sector: | Healthcare |
| Industry: | Medical Devices |
| Gic Sector: | Health Care |
| Gic Group: | Health Care Equipment & Services |
| Gic Industry: | Health Care Equipment & Supplies |
| Gic Sub Industry: | Health Care Equipment |
| Description: | Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, Switzerland, and internationally. The company products pipeline comprises alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; and Direct Sodium Removal (DSR) for the treatment of fluid overload spread across the body and heart failure. Sequana Medical NV was founded in 2006 and is headquartered in Ghent, Belgium. |
| Address: | Kortrijksesteenweg 1112, Gent, Belgium, 9051 |
| Website: | https://www.sequanamedical.com |
| Full Time Employees: | 62 |
| Updated On: | 2024-11-05 |
Highlights
| Market Capitalization: | 37669556 |
| Market Capitalization Mln: | 37.66 |
| EBITDA: | -23317588 |
| Wall Street Target Price: | 5.2 |
| Book Value: | -0.54 |
| Earnings Share: | -0.91 |
| Most Recent Quarter: | 2024-06-30 |
| Operating Margin TTM: | -90.94 |
| Return On Assets TTM: | -0.82 |
| Return On Equity TTM: | -6.90 |
| Revenue TTM: | 433500 |
| Revenue Per Share TTM: | 0.01 |
| Quarterly Revenue Growth YOY: | -0.72 |
| Gross Profit TTM: | 718000 |
| Diluted Eps TTM: | -0.91 |
Valuation
| Price Sales TTM: | 86.89 |
| Price Book MRQ: | 9.21 |
| Enterprise Value: | 55849060 |
| Enterprise Value Revenue: | 128.83 |
| Enterprise Value Ebitda: | -4.34 |
Shares
| Shares Outstanding: | 40504900 |
| Shares Float: | 20022374 |
| Percent Insiders: | 9.88 |
| Percent Institutions: | 37.31 |
Technicals
| Beta: | 0.83 |
| 52 Week High: | 4.85 |
| 52 Week Low: | 0.47 |
| 50 Day MA: | 0.89 |
| 200 Day MA: | 1.55 |
Earnings
| Report Date: | 2025-05-23 |
| Date: | 2025-03-31 |
| Before After Market: | Before Market |
| Report Date: | 2024-05-23 |
| Date: | 2024-03-31 |
| Before After Market: | Before Market |
| Eps Estimate: | -0.29 |
| Eps Difference: | 0.29 |
| Surprise Percent: | 10 |
| Report Date: | 2023-11-29 |
| Date: | 2023-09-30 |
| Eps Actual: | -0.3 |
| Eps Estimate: | -0.3 |
| Report Date: | 2023-09-14 |
| Date: | 2023-06-30 |
| Eps Actual: | -0.65 |
| Eps Estimate: | -0.32 |
| Eps Difference: | -0.33 |
| Surprise Percent: | -103.12 |
| Report Date: | 2023-05-31 |
| Date: | 2023-03-31 |
| Eps Actual: | -0.35 |
| Eps Estimate: | -0.35 |
| Report Date: | 2023-02-09 |
| Date: | 2022-12-31 |
| Before After Market: | Before Market |
| Eps Actual: | -0.32 |
| Eps Estimate: | -0.32 |
| Report Date: | 2022-11-30 |
| Date: | 2022-09-30 |
| Eps Actual: | -0.32 |
| Eps Estimate: | -0.32 |
| Report Date: | 2022-09-08 |
| Date: | 2022-06-30 |
| Eps Actual: | -0.68 |
| Eps Estimate: | -0.26 |
| Eps Difference: | -0.42 |
| Surprise Percent: | -161.53 |
| Report Date: | 2022-04-12 |
| Date: | 2022-03-31 |
| Before After Market: | Before Market |
| Eps Actual: | -0.64 |
| Eps Estimate: | -0.3 |
| Eps Difference: | -0.34 |
| Surprise Percent: | -113.33 |
| Report Date: | 2021-12-01 |
| Date: | 2021-09-30 |
| Eps Actual: | -0.32 |
| Eps Estimate: | -0.32 |
| Report Date: | 2021-09-02 |
| Date: | 2021-06-30 |
| Before After Market: | Before Market |
| Eps Actual: | -0.66 |
| Eps Difference: | -0.66 |
| Report Date: | 2021-03-17 |
| Date: | 2020-12-31 |
| Before After Market: | Before Market |
| Eps Actual: | -1.21 |
| Eps Difference: | -1.21 |
| Report Date: | 2020-09-03 |
| Date: | 2020-06-30 |
| Before After Market: | Before Market |
| Eps Actual: | -0.62 |
| Eps Difference: | -0.62 |
| Report Date: | 2020-03-19 |
| Date: | 2019-12-31 |
| Before After Market: | After Market |
| Eps Actual: | -1.19 |
| Eps Difference: | -1.19 |
| Report Date: | 2019-09-25 |
| Date: | 2019-06-30 |
| Before After Market: | Before Market |
| Eps Actual: | -0.61 |
| Eps Difference: | -0.61 |
| Report Date: | 2019-04-04 |
| Date: | 2019-03-31 |
| Before After Market: | Before Market |
| Eps Actual: | -0.42 |
| Eps Difference: | -0.42 |
| Report Date: | 2019-01-31 |
| Date: | 2018-12-31 |
| Eps Actual: | -0.32 |
| Eps Difference: | -0.32 |
| Date: | 2022-12-31 |
| Period: | +1y |
| Growth: | 0.13 |
| Earnings Estimate Year Ago Eps: | -1.25 |
| Earnings Estimate Growth: | 0.13 |
| Revenue Estimate Avg: | 923000.00 |
| Revenue Estimate High: | 930000.00 |
| Revenue Estimate Number Of Analysts: | 4.00 |
| Revenue Estimate Growth: | 1.48 |
| Eps Trend7days Ago: | -1.20 |
| Eps Trend30days Ago: | -1.20 |
| Eps Trend60days Ago: | -1.20 |
| Eps Trend90days Ago: | -1.20 |
| Date: | 2021-12-31 |
| Growth: | 0.04 |
| Earnings Estimate Year Ago Eps: | -1.31 |
| Earnings Estimate Growth: | 0.04 |
| Revenue Estimate Avg: | 371000.00 |
| Revenue Estimate Low: | 50000.00 |
| Revenue Estimate High: | 2000000.00 |
| Revenue Estimate Number Of Analysts: | 4.00 |
| Revenue Estimate Growth: | -0.61 |
| Eps Trend7days Ago: | -1.25 |
| Eps Trend30days Ago: | -1.25 |
| Eps Trend60days Ago: | -1.25 |
| Eps Trend90days Ago: | -1.25 |
| Eps Revisions Up Last30days: | 1.00 |
| Date: | 2021-09-30 |
| Revenue Estimate Low: | 10000.00 |
| Revenue Estimate High: | 10000.00 |
| Revenue Estimate Number Of Analysts: | 1.00 |
| Eps Trend7days Ago: | -0.32 |
| Eps Trend30days Ago: | -0.32 |
| Eps Trend60days Ago: | -0.32 |
| Eps Trend90days Ago: | -0.32 |
| Date: | 2024-03-31 |
| Eps Actual: | -1. |
| Date: | 2022-12-31 |
| Eps Actual: | -2.9 |
| Date: | 2020-12-31 |
| Eps Actual: | -1.8 |
| Date: | 2019-12-31 |
| Eps Actual: | -2.2 |
| Date: | 2018-12-31 |
| Eps Actual: | -0.3 |